Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/27/2010 | US20100129425 Vaginal delivery system for mirtazapine |
05/27/2010 | US20100129423 Device made at least partially of n-acetylchitosan with controlled biodissolution |
05/27/2010 | US20100129418 Method of inducing negative chemotaxis using an ellagitannin or gallotannin |
05/27/2010 | US20100129414 Bioactive Agent Delivery Using Liposomes in Conjunction With Stent Deployment |
05/27/2010 | US20100129413 Method of treating and preventing viral infections |
05/27/2010 | US20100129296 Extract of trigonella foenum-graecum |
05/27/2010 | US20100129295 Compositions for preventing and/or treating gingivitis |
05/27/2010 | US20100129294 Nattokinase for degrading and reducing amyloid fibrils assoicated with alzheimer's disease, prion diseases and other amyloidoses |
05/27/2010 | DE202009015203U1 Topisch anwendbares Alaun enthaltendes Mittel Topical application of alum-containing agent |
05/27/2010 | CA2781597A1 Pharmaceutical articles coated with lubricious coatings |
05/27/2010 | CA2781591A1 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone praticles as scaffolds for tissue regeneration |
05/27/2010 | CA2744377A1 Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient |
05/27/2010 | CA2744211A1 Wet granulation of tenofovir, emtricitabine and efavirenz |
05/27/2010 | CA2744207A1 Polyvalent rna-nanoparticle compositions |
05/27/2010 | CA2744150A1 Novel form of administering osteogenic protein complexes |
05/27/2010 | CA2744142A1 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof |
05/27/2010 | CA2744048A1 Single-time vaccines |
05/27/2010 | CA2743967A1 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain |
05/27/2010 | CA2743959A1 Liposomal composition for convection-enhanced delivery to the central nervous centre |
05/27/2010 | CA2743261A1 Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
05/27/2010 | CA2743260A1 Intravaginal delivery system and process for manufacturing it |
05/27/2010 | CA2741041A1 Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivative |
05/27/2010 | CA2741038A1 Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate |
05/27/2010 | CA2738732A1 Pharmaceutical composition of a potent hcv inhibitor for oral administration |
05/27/2010 | CA2738616A1 Aerosol formulation for the inhalation of beta agonists |
05/27/2010 | CA2737045A1 Therapeutic protein formulations |
05/27/2010 | CA2708334A1 Process for recovering florfenicol from pharmaceutical compositions |
05/26/2010 | EP2189475A2 Fibroblast growth factor-like polypeptides |
05/26/2010 | EP2189163A1 A composition for treatment of diabetes mellitus and a preparation and an use thereof |
05/26/2010 | EP2189162A1 Methods for the treatment of cellular proliferative disorders |
05/26/2010 | EP2189156A1 Lys-Pro and Lys-Pro-Thr for the manufacture of a cosmetic composition |
05/26/2010 | EP2189154A1 Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof |
05/26/2010 | EP2189153A2 Article of manufacture used in contact with human body surfaces |
05/26/2010 | EP2187980A1 Hydrogel polymeric compositions and methods |
05/26/2010 | EP2187968A2 Thermo-kinetic mixing for pharmaceutical applications |
05/26/2010 | EP2187932A1 Protein formulations comprising gdf-5 in aqueous acidic solution |
05/26/2010 | EP2187886A1 Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt |
05/26/2010 | EP2187881A1 Powdered medicament for nasal delivery of ascorbic acid for reducing apomorphine induced toxicity to ciliated tissue |
05/26/2010 | EP2187877A2 Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules |
05/26/2010 | EP2187875A1 Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol |
05/26/2010 | EP2187874A2 Sustained release compositions of trimetazidine and process for preparation thereof |
05/26/2010 | EP2187873A2 Abuse resistant drugs, method of use and method of making |
05/26/2010 | EP2187872A1 Extended release compositions comprising mycophenolate sodium and processes thereof |
05/26/2010 | EP2187871A1 Mixtures comprising pellitorin and uses thereof |
05/26/2010 | EP2187870A1 Method of producing a system for delivering active ingredients of plant origin |
05/26/2010 | EP2187869A1 Improved platinum drug formulations |
05/26/2010 | EP2187867A1 Injectable pharmaceutical formulation of taxoids |
05/26/2010 | EP2187866A2 Dexamethasone formulations in a biodegradable material |
05/26/2010 | EP2187759A1 Erythritol-based hard coatings |
05/26/2010 | EP2187743A2 Formulations for treatment of ocular diseases or conditions |
05/26/2010 | EP1605971B1 Immunogenic composition and methods |
05/26/2010 | EP1541155B1 Material for formation of carbon dioxide external preparation |
05/26/2010 | EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
05/26/2010 | EP1132383B1 Novel agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine |
05/26/2010 | CN201481825U cataplasma |
05/26/2010 | CN1985900B Colon-targeting oral compound rubarb preparation |
05/26/2010 | CN1980646B Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients |
05/26/2010 | CN1969965B Ointment for treating bone injuries |
05/26/2010 | CN1969814B Nasal administered preparation of melatonin |
05/26/2010 | CN1965898B Compound capsule of red sage root and method for preparing same |
05/26/2010 | CN1961961B A pharmaceutical formulation and preparation process thereof |
05/26/2010 | CN1960736B Anti-infectious hydrogel compositions |
05/26/2010 | CN1951494B Compound Chinese medicinal preparation for treating affection of external wind and cold and preparation method thereof |
05/26/2010 | CN1951483B Hybrid safflower oil and preparation method thereof |
05/26/2010 | CN1943565B Biological degradable nano medicinal capsule with MRI tracer effect and its preparing method |
05/26/2010 | CN1942175B Sustained-release tramadol formulations with 24-hour efficacy |
05/26/2010 | CN1935277B Preparation for the prophylaxis of restenosis |
05/26/2010 | CN1935211B Medicinal composition for treating cerebral ischemia |
05/26/2010 | CN1931245B Medicine for treating gouty arthritis and its preparation process and application |
05/26/2010 | CN1913878B Transdermal delivery of hormones without the need of penetration enhancers |
05/26/2010 | CN1899456B Pile ointment |
05/26/2010 | CN1899370B Compound calyx melo extract tablet |
05/26/2010 | CN1895546B Lycium chinensis polyose medicinal composition with therapeutic and health-care functions |
05/26/2010 | CN1895353B Preparation of compound Danshen tablets |
05/26/2010 | CN1893932B Microemulsion preconcentrate comprising a renin inhibitor |
05/26/2010 | CN1893916B Cosmetic and dermatologic oxygen carrier system |
05/26/2010 | CN1879745B A veterinary Chinese medicinal powder for treating avian viral disease |
05/26/2010 | CN1879711B A Chinese medicinal composition for treating gastric disease, its preparation process and detection method |
05/26/2010 | CN1875022B Tocopherol-modified therapeutic drug compounds |
05/26/2010 | CN1870982B Composition containing reduced coenzyme q |
05/26/2010 | CN1868530B Traditional Chinese medicine composition for treating cyclomastopathy and its preparation method |
05/26/2010 | CN1856318B Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
05/26/2010 | CN1853654B Oral preparation containing pearl and vitamine |
05/26/2010 | CN1840002B Chinese medicinal preparation for treating chronic obstructive lung disease (COPD) and preparation method thereof |
05/26/2010 | CN1832751B Periodontal disease therapeutic and/or preventive composition |
05/26/2010 | CN1827107B Substained analgesia achieved with buprenorphine |
05/26/2010 | CN1816626B Antisense oligonucleotide having anticancerous activity |
05/26/2010 | CN1810282B Soft black bone chicken and white phoenix capsule and its preparation process and quality control method |
05/26/2010 | CN1803189B Use of neurotoxin therapy for treatment of urologic and related disorders |
05/26/2010 | CN1803144B Pharmaceutical composition containing clofibrate compound and B family vitamin |
05/26/2010 | CN1799622B Mind-tranquilizing brain-replenishing soft capsule, its preparation process and quality control method |
05/26/2010 | CN1799559B Chinese medicinal gel formulation, its preparation process and quality control method |
05/26/2010 | CN1799557B Chinese medicinal gel formulation, its preparation process and quality control method |
05/26/2010 | CN1794976B Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals |
05/26/2010 | CN1781545B Method for extracting herbal medicine |
05/26/2010 | CN1771912B Orally taken nanometer protein polypetide composite nano-particle and its preparation |
05/26/2010 | CN1764468B Skin protecting composition |
05/26/2010 | CN1764439B Process for the production of cross-linked gelatin beadlets |
05/26/2010 | CN1758920B Cystitis treatment with high dose chondroitin sulfate |
05/26/2010 | CN1758899B Dosage form having a saccharide matrix |